James A. Tartal
38 IP cases indexed. Covers patent matters.
Cases Presided Over
38 cases indexed | Page 2 of 2
Fluidmaster, Inc. v.Danco, Inc. et al.
Fluidmaster successfully petitioned the PTAB against Danco, Inc., leading to the institution of trial on all 14 claims. The Board found sufficient evidence that the patent's features were obvious under 35 U.S.C. § 103 using various prior art references. This decision significantly advances Fluidmaster’s challenge in related district court litigation.
Fluidmaster, Inc. v.Danco, Inc. et al.
The PTAB panel majority found that the cited prior art references teach or suggest all limitations of claims 1-14, rendering them unpatentable under 35 U.S.C. § 103. The Board specifically construed key terms like 'overflow tube' and 'Flow Limitations' to support Petitioner’s reading, though ultimately found the overflow tube limitation was limiting in scope.
Fluidmaster, Inc. v.Danco, Inc. et al.
The PTAB found several independent claims unpatentable over prior art references (Brown and Ho) using grounds of obviousness. The Board adopted a broad construction for 'integrally molded with' as 'molded together as a single structure.'
Fluidmaster, Inc. v.Danco, Inc. et al.
The PTAB found 16 claims unpatentable over prior art references, primarily based on obviousness (35 U.S.C. § 103). The Board upheld its construction of 'integrally molded with' as 'molded together as a single structure.'
Abbott Laboratories et al. v.MIRACOR MEDICAL SA
Abbott Laboratories challenged MIRACOR MEDICAL SA's cardiac assist pump patents based on obviousness (35 U.S.C. § 103). The Board adopted the Patent Owner’s broader claim constructions for key terms like 'magneto coupling,' leading to the institution of the IPR.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over U.S. Patent 10,709,364 B2, leading the PTAB to terminate the IPR before any merits were decided. The settlement agreement was also designated as confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.
Catalyst OrthoScience Inc. v.Shoulder Innovations, Inc.
Catalyst OrthoScience Inc.'s Post-Grant Review petition against Shoulder Innovations, Inc. was denied by the PTAB. The Board found that Petitioner failed to establish a 'compelling merits' showing for either obviousness (103) or indefiniteness (112).
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.